ForumIAS LATEST
- SFG 2027 Level-1 starts 21 Dec. 2026 at 7 AM | Entrance Test on 22 Nov. at 9:30 AM Click Here to know more →
- Interview Guidance initiative by ForumIAS – UPSC CSE 2026 Click Here to know more →
- FRC 2027: SFG Residential program | accepting application for Tranche-2 Click Here to know more →
News– Researchers from Switzerland have announced the development of a gene-editing technique that may potentially aid in the treatment of Stargardt disease.
About Stargardt Disease
- It is a rare inherited genetic disorder that leads to progressive vision loss, especially in children and young adults.
- Cause: The disease is caused by mutations in the ABCA4 gene, which disrupts the body’s ability to process Vitamin A properly. This leads to the accumulation of lipofuscin, a fatty substance that builds up on the macula—the central part of the retina responsible for sharp, central vision.
- Bilateral: Stargardt disease typically affects both eyes (bilateral), resulting in the gradual loss of central visual acuity in both eyes.
- No Cure: There is currently no cure or effective treatment for Stargardt disease, though research continues to explore potential therapies.



